This inventor holds 4 USPTO granted patents. Top assignees: Medical Diagnostic Laboratories, LLC, Other. Active years: 2011-2020.
Company Filing History:
3 out of 80 
1 out of 834,411 Years Active: 2011-2020
Title: Innovations of Sean Chadwick
Introduction
Sean Chadwick is an accomplished inventor based in Florence, NJ (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of Methicillin Resistant Staphylococcus aureus (MRSA). With a total of 4 patents to his name, Chadwick's work has the potential to impact public health positively.
Latest Patents
Chadwick's latest patents focus on the discovery of novel single nucleotide polymorphisms (SNPs) in the penicillin binding protein (pbp3) gene. The presence of G88A and/or G2047A SNPs serves as an accurate and reliable biomarker for identifying community-associated MRSA (CA-MRSA). His inventions provide essential reagents for detecting these SNPs and outline methods for screening biological samples, particularly from humans, to determine the presence of CA-MRSA.
Career Highlights
Throughout his career, Sean Chadwick has worked with various organizations, including Medical Diagnostic Laboratories, LLC. His expertise in medical diagnostics has allowed him to develop innovative solutions that address critical health challenges.
Collaborations
Chadwick has collaborated with notable professionals in his field, including Scott E Gygax and Martin E Adelson. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Sean Chadwick's contributions to the field of medical diagnostics through his innovative patents highlight his commitment to improving public health. His work in identifying biomarkers for MRSA detection is a testament to his expertise and dedication to advancing medical science.